Evidence map›Paper›PMID 35994694›Full record

ReviewJCO global oncology2022

Quality and Safety With Technological Advancements in Radiotherapy: An Overview and Journey Narrative From a Low- and Middle-Income Country Institution.

Jifmi Jose Manjali, Rahul Krishnatry, Jatinder R Palta, J P Agarwal

Abstract readReview
In one paragraph

Review in JCO global oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jifmi Jose ManjaliDepartment of Radiation Oncology, Tata Memorial Centre (TMH/ACTREC), Mumbai, India.
Rahul KrishnatryDepartment of Radiation Oncology, Tata Memorial Centre (TMH/ACTREC), Mumbai, India.ORCID 0000-0003-4511-7782
Jatinder R PaltaHomi Bhabha National Institute (HBNI), Anushakti Nagar, Mumbai, India.
J P AgarwalDepartment of Radiation Oncology, Tata Memorial Centre (TMH/ACTREC), Mumbai, India.ORCID 0000-0003-0430-8558

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo present an overview of quality and safety in radiotherapy from the context of low- and middle-income countries on the basis of a recently conducted annual meeting of our institution and our experience of implementing an error management system at our center.

methodsThe minutes of recently concluded annual Evidence-Based Medicine (EBM-2021) meeting on the basis of technology in radiation oncology were reviewed. The session on quality and safety, which had international experts as speakers, was reviewed. Along with this, we reviewed the literature for preventive and reactive measures proposed to manage errors including error reporting and learning systems (ILSs). Concise summary for the same was prepared for this article.

resultsWe also reviewed the journey of development of our institutional ILS and present here a summary of achievements, challenges, and future vision.

conclusionPreventive and reactive measures must be followed to achieve high-quality and safe radiotherapy. Despite resource constraints, a successful ILS program can be developed in a low- and middle-income country center by first understanding the patterns of error and developing one that suits the working ecosystem.

Indexed as

Radiation OncologyEcosystemHealth FacilitiesIncomeNarration

Identifiers

PMID35994694
PMCPMC9470131

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.